This research was conducted by Hai Fang and team from Peking University and published in The Lancet Regional Health: Western Pacific. The study demonstrated that the introduction of PCV13 into China’s national immunization program is cost-effective, while provincial estimates support prioritizing the introduction of PCV13 in economically underdeveloped provinces.
From both sides of the needle: Understanding effective interventions for facilitating non-national immunization program vaccine decision making in China
This study was conducted by Professor Xiaohua Ying and his team from Fudan University and published in Human Vaccines & Immunotherapeutics. This study aims to explore the complexity of decision-making for non-National Immunization Program (non-NIP) vaccines (voluntary and self-paid) in China, and how effective communication between healthcare providers and recipients can promote vaccine uptake. The research integrates perspectives from both providers and recipients to identify strategies that facilitate vaccination and analyze their underlying mechanisms, emphasizing the importance of multi-stakeholder collaboration and sustained motivation in vaccination decision-making.